Martin Javier San Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 weeks, 5 days ago
Martin Javier San has an estimated net worth of at least $10.5 million*, as of Oct. 29, 2025. They own 198,497 shares of ARWR stock. They have sold 88,671 shares of ARWR stock since 2021, for an estimated $2.8 million.
Martin Javier San $ARWR SEC Form 4 Insider Trading
Martin Javier San has filed a total of 10 insider trades in $ARWR since 2021. Their most recent trade was a sale of 4,403 shares, made on Jan 05, 2024. Their largest trade was a sale of 19,300 shares, made on Nov 21, 2022. We estimate that they now own 198,497 shares of $ARWR, worth an estimated $7.7 million.
Insider Trading at $ARWR
There have been a total of 171 insider trades reported at $ARWR since 2021, with 3,655 shares purchased and 1.8 million shares sold. The most active insider traders in $ARWR stock have been Christopher Richard Anzalone, Patrick O'Brien, and Kenneth Allen Myszkowski. The most recent trade was a sale of 20,000 shares reported by James C Hamilton (Chief Medical Officer), made on Oct 01, 2025.
History of Insider Stock Trades by Martin Javier San
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ATHA
|
Sale | 10,842 | Jul 01, 2025 | July 2, 2025, 4:33 p.m. |
|
ATHA
|
Sale | 10,826 | Jan 02, 2025 | Jan. 3, 2025, 6:05 p.m. |
ARWR
|
Sale | 4,403 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |
|
ARWR
|
Sale | 800 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |
|
ARWR
|
Sale | 3,100 | Jan 05, 2024 | Jan. 8, 2024, 6:16 p.m. |
|
ARWR
|
Sale | 4,942 | Nov 20, 2023 | Nov. 22, 2023, 3:31 p.m. |
|
ARWR
|
Sale | 14,758 | Nov 20, 2023 | Nov. 22, 2023, 3:31 p.m. |
|
ARWR
|
Sale | 19,300 | Nov 21, 2022 | Nov. 22, 2022, 7:05 p.m. |
|
ARWR
|
Sale | 200 | Nov 21, 2022 | Nov. 22, 2022, 7:05 p.m. |
|
ARWR
|
Sale | 100 | Nov 19, 2021 | Nov. 22, 2021, 5:56 p.m. |
|
ARWR
|
Sale | 13,704 | Nov 19, 2021 | Nov. 22, 2021, 5:56 p.m. |
|
ARWR
|
Sale | 5,696 | Nov 19, 2021 | Nov. 22, 2021, 5:56 p.m. |
$ARWR Executives and Stock Owners with Insider Trades
-
Christopher Richard Anzalone, Chief Executive Officer
-
Patrick O'Brien, COO and General Counsel
-
Kenneth Allen Myszkowski, Chief Financial Officer
-
Martin Javier San, Chief Medical Officer
-
James C Hamilton, Chief Discovery/Trans Medicine
-
James C Hamilton, Chief Medical Officer
-
Patrick O'Brien, General Counsel
-
Tracie Oliver, Chief Commercial Officer
-
James Hassard, Chief Commercial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.